2H0
Exicure, Inc. does not have significant operations. Previously, the company focused on developing of nucleic acid therapies targeting ribonucleic acid against validated targets. Exicure, Inc. was founded in 2011 and is headquartered in Redwood City, California.
Market Cap & Net Worth: 2H0 (2H0)
2H0 (F:2H0) has a market capitalization of $24.73 Million (€24.09 Million) as of March 18, 2026. Listed on the F stock exchange, this Germany-based company holds position #28868 globally and #3178 in its home market, demonstrating a 16.67% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying 2H0's stock price €3.78 by its total outstanding shares 6373869 (6.37 Million).
2H0 Market Cap History: 2026 to 2026
2H0's market capitalization history from 2026 to 2026. Data shows growth from $24.73 Million to $24.73 Million (0.00% CAGR).
2H0 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how 2H0's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 2H0 by Market Capitalization
Companies near 2H0 in the global market cap rankings as of March 18, 2026.
Key companies related to 2H0 by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
2H0 Historical Marketcap From 2026 to 2026
Between 2026 and today, 2H0's market cap moved from $24.73 Million to $ 24.73 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €24.73 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of 2H0 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $24.73 Million USD |
| MoneyControl | $24.73 Million USD |
| MarketWatch | $24.73 Million USD |
| marketcap.company | $24.73 Million USD |
| Reuters | $24.73 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.